25/05/2013 00:27:39 Free Membership Login
Regen Therapeut
   

Regen Therapeutics Company Financial Information
Regen Therapeutics share price | Regen Therapeutics company information | Regen Therapeutics Share Charts | Regen Therapeutics Share News
 Company name: Regen Therapeut
 EPIC: RGT (delisted) Trading Currency: GBX
 Market Sector: AIMT ISIN: GB00B28XMY25
 Market Segment: AIMI Share Type: DE
 WWW Address: http://www.regentherapeutics.com/ Description: ORD 0.01P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 0.48 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 1.85 389.45 1.14 -2.67 - - - -

Regen Therapeutics Key Figures

(at previous day's close)
Market Cap.1.85m
Shares In Issue389.45m
Prev. Close0.48
PE Ratio- 
Dividend Yield-%
EPS - basic-2.67p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.14p
Return On Equity (ROE)-60.17%
Operating Margin-1,352.76%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt0.49m
Gross Gearing29.86%
Quick Assets0.13m
Net Working Capital-0.25m
Intangibles / Fixed Assets99.99%
Turnover PS0.01p
Pre-Tax Profit PS-0.19p
Retained Profit PS-0.19p
Cash PS0.01p
Net Cash PS-0.10p
Net Tangible Asset Value PS *-0.09p
Net Asset Value PS0.31p
Spread- (-%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Regen Therapeutics Balance Sheet

LSE:RGT:Liabilities+EQLSE:RGT:Assets

Regen Therapeutics Share Price

Sorry No Data Available

Regen Therapeutics Share Price (5 years)

Regen Therapeutics Historic Returns

Sorry No Data Available

Regen Therapeutics Key Management Ratios

Regen Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.00 
Tobin's Q Ratio (excl. intangibles)9.54 
Dividend Yield-%
Market-to-Book Ratio1.52 
Price-to-Pre-Tax Profit PS-2.44 
Price-to-Retained Profit PS-2.53 
Price-to-Cash Flow PS-3.38 
Price-to-Sales PS33.00 
Price-to-Net Tangible Asset Value PS-5.27 
Price-to-Cash PS60.88 
Net Working Capital PS-0.06 
Price Pct to Working Capital PS-7.36%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Regen Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio7.62%
Debt-to-Equity Ratio0.08 
Debt-to-Equity Ratio (excl. Intgbl)-0.28 
Debt-to-Equity Market Value0.05 
Net Gearing28.11%
Net Gearing (excl. Intangibles)293.91%
Gross Gearing29.86%
Gross Gearing (excl. Intangibles)312.29%
Gearing Under 1 Year24.08%
Gearing Under 1 Year (excl. Intgbl)251.83%
Assets/Equity1.43 
Cash/Equity2.50 
(Liquidity Ratios)
Net Working Capital to Total Assets-14.53%
Current Ratio0.40 
Quick Ratio (Acid Test)0.30 
Liquidity Ratio0.07 
Cash & Equiv/Current Assets18.39%
(Solvency Ratios)
Enterprise Value1.92m
CFO/Sales-9.77 
CFO/Attributable Profit- 
CFO/Assets-0.32 
CFO/Debt-1.06 
Total Debt/Equity Market Value0.28 
Total Debt/Sales9.21 
Total Debt/Pre-Tax Profit-0.68 
Total Debt0.52m
Total Debt/Net Current Assets-2.06%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-52.99%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-5.52%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)
1.1448Sorry No Data Available
Alpha (60-Mnth)Alpha (36-Mnth)
-0.0761Sorry No Data Available

Regen Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-57.75%
Return On Assets (ROA)-39.34%
Net Profit Margin-1,302.18%
Assets Turnover0.03 
Return On Equity (ROE)-60.17%
Return On Investment (ROI)-53.02%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-1,302.18%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.04 
Fixed Assets Turnover0.03 
Current Assets Turnover0.29 
Net Working Capital Turnover 
Inventory Turnover1.68 
(Other Operating Ratios)
Total Assets-to-Sales33.10 
Debtors-to-Sales235.75%
Debt Collection Period860.48Days

Regen Therapeutics Dividends

Sorry No Data Available

Regen Therapeutics Fundamentals
 31 Dec 2006 (GBP)31 Dec 2007 (GBP)31 Dec 2008 (GBP)31 Dec 2009 (GBP)
turnover0.40-0.06-0.09-0.06-m
pre tax profit-2.37--2.55--1.51--0.76-m
attributable profit-2.25--2.39--1.46--0.73-m
retained profit-2.25--2.39--1.46--0.73-m
eps - basic-0.38 -25.70 -12.27 -2.67 
eps - diluted-0.38 -25.70 -12.27 -2.67 
dividends per share- - - - 

Regen Therapeutics Balance Sheet

 31 Dec 2006 (GBP)31 Dec 2007 (GBP)31 Dec 2008 (GBP)31 Dec 2009 (GBP)
LSE:RGT:Liabilities+EQLSE:RGT:AssetsLSE:RGT:Liabilities+EQLSE:RGT:AssetsLSE:RGT:Liabilities+EQLSE:RGT:AssetsLSE:RGT:Liabilities+EQLSE:RGT:Assets
 31 Dec 2006 (GBP)31 Dec 2007 (GBP)31 Dec 2008 (GBP)31 Dec 2009 (GBP)
ASSETS
fixed assets fixed assets0.030.85%0.000.09%0.000.05%0.000.01%m
intangibles intangibles2.1870.83%1.9567.07%1.7688.78%1.5690.44%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.020.65%0.010.23%0.031.44%0.042.21%m
debtors debtors0.3411.19%0.3612.36%0.178.46%0.105.59%m
cash & securities cash & securities0.5116.48%0.5920.25%0.031.27%0.031.76%m
TOTAL3.08100%2.90100%1.98100%1.73100%m
LIABILITIES
creditors - short creditors - short0.6320.50%0.3612.48%0.5427.32%0.4224.08%m
creditors - long creditors - long0.103.24%0.103.45%0.105.05%0.105.78%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL0.7323.74%0.4615.93%0.6432.37%0.5229.86%m
EQUITY
ord cap, reserves ord cap, reserves2.3576.26%2.4484.07%1.3467.63%1.2170.14%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL2.3576.26%2.4484.07%1.3467.63%1.2170.14%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Regen Therapeutics Cash Flow Statement

31 Dec 2006 (GBP)31 Dec 2007 (GBP)31 Dec 2008 (GBP)31 Dec 2009 (GBP)
Operating CF-2.16-2.19-0.91-0.55m
Pre-Financing CF-2.18-2.20-1.02-0.59m
Retained CF0.01101.63-0.560.01m

Regen Therapeutics Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
HB Markets plcMarket Maker(MMF)Broker/DealerHOODHOPBGB2L
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us lse rgt130525 00:27